• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[良性阵发性位置性眩晕发病中骨矿物质代谢的损害]

[The impairment of bone-mineral metabolism in the development of benign paroxysmal positional vertigo].

作者信息

Kutlubaev M A, Rakhmatullin A R

机构信息

Bashkir State Medical University, Ufa, Russia; Kuvatov Republican Clinical Hospital, Ufa, Russia.

出版信息

Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(12):139-142. doi: 10.17116/jnevro2019119121139.

DOI:10.17116/jnevro2019119121139
PMID:31994527
Abstract

Benign paroxysmal positional vertigo (BPPV) is one of the most common causes of systemic vertigo in clinical practice. The results of recent research demonstrated the decrease of bone mineral density, level of vitamin D and estrogen in blood serum in patients with BPPV. In summary these data points at the relationship between osteoporosis/osteopenia and BPPV. This association is most obvious in menopausal women and in those with recurrent BPPV. Patients with recurrent BPPV should undergo investigation for osteoporosis/osteopenia. Treatment of bone-mineral metabolism allows decreasing the frequency of BPPV recurrence, however more research is needed in this area.

摘要

良性阵发性位置性眩晕(BPPV)是临床实践中系统性眩晕最常见的病因之一。近期研究结果表明,BPPV患者的骨密度、血清维生素D水平和雌激素水平均有所下降。综上所述,这些数据表明骨质疏松症/骨质减少与BPPV之间存在关联。这种关联在绝经后女性和复发性BPPV患者中最为明显。复发性BPPV患者应接受骨质疏松症/骨质减少的检查。骨矿物质代谢的治疗可降低BPPV复发的频率,然而该领域仍需更多研究。

相似文献

1
[The impairment of bone-mineral metabolism in the development of benign paroxysmal positional vertigo].[良性阵发性位置性眩晕发病中骨矿物质代谢的损害]
Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(12):139-142. doi: 10.17116/jnevro2019119121139.
2
Bone mineral density and serum 25-hydroxyvitamin D in subtypes of idiopathic benign paroxysmal positional vertigo.特发性良性阵发性位置性眩晕各亚型的骨密度和血清 25-羟维生素 D。
Am J Otolaryngol. 2020 Jan-Feb;41(1):102313. doi: 10.1016/j.amjoto.2019.102313. Epub 2019 Oct 17.
3
Evaluation of bone mineral density and 25-(OH) vitamin D levels in middle-aged and elderly women with recurrent benign paroxysmal positional vertigo.中老年复发性良性阵发性位置性眩晕女性骨密度及25-(羟)维生素D水平的评估
Acta Otolaryngol. 2020 Feb;140(2):89-93. doi: 10.1080/00016489.2019.1692146. Epub 2019 Dec 26.
4
Association between bone mineral density and benign paroxysmal positional vertigo: a meta-analysis.骨密度与良性阵发性位置性眩晕的相关性:荟萃分析。
Eur Arch Otorhinolaryngol. 2019 Jun;276(6):1561-1571. doi: 10.1007/s00405-019-05345-4. Epub 2019 Apr 27.
5
The Relationship Between Disorders of Bone Metabolism and Benign Paroxysmal Positional Vertigo: A Systematic Review.骨代谢紊乱与良性阵发性位置性眩晕的关系:系统评价。
Ear Hear. 2021;42(6):1462-1471. doi: 10.1097/AUD.0000000000001063.
6
Bone mineral density and serum 25-hydroxyvitamin D in patients with idiopathic benign paroxysmal positional vertigo.特发性良性阵发性位置性眩晕患者的骨矿物质密度和血清25-羟基维生素D
J Vestib Res. 2018;27(5-6):287-294. doi: 10.3233/VES-170625.
7
Impaired Calcium Metabolism in Benign Paroxysmal Positional Vertigo: A Topical Review.良性阵发性位置性眩晕的钙代谢障碍:专题综述。
J Neurol Phys Ther. 2019 Apr;43 Suppl 2:S37-S41. doi: 10.1097/NPT.0000000000000273.
8
Low 25-hydroxyvitamin D levels in postmenopausal female patients with benign paroxysmal positional vertigo.绝经后女性良性阵发性位置性眩晕患者25-羟维生素D水平较低
Acta Otolaryngol. 2018 May;138(5):443-446. doi: 10.1080/00016489.2017.1416168. Epub 2017 Dec 22.
9
Low bone mineral density and vitamin D deficiency in patients with benign positional paroxysmal vertigo.良性阵发性位置性眩晕患者的低骨矿物质密度和维生素D缺乏
Eur Arch Otorhinolaryngol. 2015 Sep;272(9):2249-53. doi: 10.1007/s00405-014-3175-3. Epub 2014 Jun 29.
10
Biochemical markers of bone turnover in benign paroxysmal positional vertigo.良性阵发性位置性眩晕中骨转换的生化标志物
PLoS One. 2017 May 3;12(5):e0176011. doi: 10.1371/journal.pone.0176011. eCollection 2017.